Liu GJ, Feng RN, Luo C, Bi S (2010) Lack of association between interleukin-1 alpha, beta polymorphisms and Parkinson’s disease. Neurosci Lett. 480(2):158–161. https://doi.org/10.1016/j.neulet.2010.06.032
Article
CAS
PubMed
Google Scholar
Pascale E, Passarelli E, Purcaro C, Vestri AR, Fakeri A, Guglielmi R et al (2011) Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort. Acta Neurol Scand. 124(3):176–181. https://doi.org/10.1111/j.1600-0404.2010.01441.x
Article
CAS
PubMed
Google Scholar
Xu X, Li D, He Q, Gao J, Chen B, Xie A (2011) Interleukin-18 promoter polymorphisms and risk of Parkinson’s disease in a Han Chinese population. Brain Res. 1381:90–94. https://doi.org/10.1016/j.brainres.2011.01.025
Article
CAS
PubMed
Google Scholar
Li D, He Q, Li R, Xu X, Chen B, Xie A (2012) Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson’s disease. Neurosci Lett. 513(2):183–186. https://doi.org/10.1016/j.neulet.2012.02.033
Article
CAS
PubMed
Google Scholar
Ryczko D, Dubuc R (2017) Dopamine and the brainstem locomotor networks: from lamprey to human. Front Neurosci. 11:295. https://doi.org/10.3389/fnins.2017.00295
Article
PubMed
PubMed Central
Google Scholar
Zhou YT, Yang JF, Zhang YL, Wang XY, Chan P (2008) Protective role of interlekin-1 alpha gene polymorphism in Chinese Han population with sporadic Parkinson’s disease. Neurosci Lett. 445(1):23–25. https://doi.org/10.1016/j.neulet.2008.08.054
Article
CAS
PubMed
Google Scholar
San Luciano M, Ozelius L, Lipton RB, Raymond D, Bressman SB, Saunders-Pullman R (2012) Gender differences in the IL6 -174G > C and ESR2 1730G > A polymorphisms and the risk of Parkinson’s disease. Neurosci Lett. 506(2):312–316. https://doi.org/10.1016/j.neulet.2011.11.032
Article
CAS
PubMed
Google Scholar
Wu YR, Chen CM, Hwang JC, Chen ST, Feng IH, Hsu HC et al (2007) Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson’s disease in Taiwan. J Neural Transm (Vienna). 114(9):1173–1177. https://doi.org/10.1007/s00702-007-0726-4
Article
CAS
PubMed
Google Scholar
Krüger R, Hardt C, Tschentscher F, Jäckel S, Kuhn W, Müller T et al (2000) Genetic analysis of immunomodulating factors in sporadic Parkinson’s disease. J Neural Transm (Vienna). 107(5):553–562. https://doi.org/10.1007/s007020070078
Article
PubMed
Google Scholar
Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B et al (2005) Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet. 133B(1):88–92. https://doi.org/10.1002/ajmg.b.30136
Article
PubMed
Google Scholar
Wahner AD, Sinsheimer JS, Bronstein JM, Ritz B (2007) Inflammatory cytokine gene polymorphisms and increased risk of Parkinson’s disease. Arch Neurol. 64(6):836–840. https://doi.org/10.1001/archneur.64.6.836
Article
PubMed
Google Scholar
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Opala G, Bialecki P et al (2007) Interleukin-10 gene polymorphism in Parkinson’s disease patients. Arch Med Res. 38(8):858–863. https://doi.org/10.1016/j.arcmed.2007.06.006
Article
CAS
PubMed
Google Scholar
Infante J, García-Gorostiaga I, Sánchez-Juan P, Sánchez-Quintana C, Gurpegui JL, Rodríguez-Rodríguez E et al (2008) Inflammation-related genes and the risk of Parkinson’s disease: a multilocus approach. Eur J Neurol. 15(4):431–433. https://doi.org/10.1111/j.1468-1331.2008.02092.x
Article
CAS
PubMed
Google Scholar
Ross OA, O'Neill C, Rea IM, Lynch T, Gosal D, Wallace A et al (2004) Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson’s disease in the Irish. Hum Immunol. 65(4):340–346. https://doi.org/10.1016/j.humimm.2004.01.015
Article
CAS
PubMed
Google Scholar
McGeer PL, Yasojima K, McGeer EG (2002) Association of interleukin-1 beta polymorphisms with idiopathic Parkinson’s disease. Neurosci Lett. 326(1):67–69. https://doi.org/10.1016/s0304-3940(02)00300-2
Article
CAS
PubMed
Google Scholar
Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Bono G et al (2018) TNF-α -308 G/A and -238 G/A promoter polymorphisms and sporadic Parkinson’s disease in an Italian cohort. J Neurol Sci. 385:45–48. https://doi.org/10.1016/j.jns.2017.12.011
Article
CAS
PubMed
Google Scholar
Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B et al (2005) Investigation of genes coding for inflammatory components in Parkinson’s disease. Mov Disord. 20(5):569–573. https://doi.org/10.1002/mds.20378
Article
PubMed
Google Scholar
Papageorgiou IE, Lewen A, Galow LV, Cesetti T, Scheffel J, Regen T et al (2016) TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ. Proc Natl Acad Sci USA. 113(1):212–217. https://doi.org/10.1073/pnas.1513853113
Article
CAS
PubMed
Google Scholar
Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martínez C et al (2004) Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer’s and Parkinson’s disease. Neurosci Lett. 370(2-3):151–154. https://doi.org/10.1016/j.neulet.2004.08.016
Article
CAS
PubMed
Google Scholar
Sahin-Calapoglu N, Demirci S, Calapoglu M, Yasar B (2016) A case-control association study of RANTES (-28C > G) polymorphism as a risk factor for Parkinson’s disease in Isparta, Turkey. Parkinson’s Dis. 2016:5042604. https://doi.org/10.1155/2016/5042604
Article
CAS
Google Scholar
Shen R, Lin S, He L, Zhu X, Zhou Z, Chen S et al (2019) Association of two polymorphisms in CCL2 with Parkinson’s disease: a case-control study. Front Neurol. 10:35. https://doi.org/10.3389/fneur.2019.00035
Article
PubMed
PubMed Central
Google Scholar
Chu K, Zhou X, Luo BY (2012) Cytokine gene polymorphisms and Parkinson’s disease: a meta-analysis. Can J Neurol Sci. 39(1):58–64. https://doi.org/10.1017/s0317167100012695
Article
PubMed
Google Scholar
Dai D, Lin P, Wang Y, Zhou X, Tao J, Jiang D et al (2014) Association of NQO1 and TNF polymorphisms with Parkinson’s disease: a meta-analysis of 15 genetic association studies. Biomed Rep. 2(5):713–718. https://doi.org/10.3892/br.2014.296
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Zhao T, Xu C, Yu H (2018) Four polymorphisms in the IL-22 gene and the risk of cancer: a meta-analysis. J Evid Based Med. 11(2):101–104. https://doi.org/10.1111/jebm.12296
Article
PubMed
Google Scholar
Boonpheng B, Thongprayoon C, Cheungpasitporn W (2018) The comparison of risk of stroke in patients with peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. J Evid Based Med. 11(3):158–168. https://doi.org/10.1111/jebm.12315
Article
PubMed
Google Scholar
Arman A, Isik N, Coker A, Candan F, Serap Becit K, List EO (2010) Association between sporadic Parkinson’s disease and interleukin-1beta -511 gene polymorphisms in the Turkish population. Eur Cytokine Netw. 21(2):116–121. https://doi.org/10.1684/ecn.2010.0186
Article
CAS
PubMed
Google Scholar
Dodel RC, Lohmüller F, Du Y, Eastwood B, Gocke P, Oertel WH et al (2001) A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson’s disease. Neurology. 56(7):982–983. https://doi.org/10.1212/wnl.56.7.982
Article
CAS
PubMed
Google Scholar
Mattila KM, Rinne JO, Lehtimäki T, Röyttä M, Ahonen JP, Hurme M (2002) Association of an interleukin 1B gene polymorphism (-511) with Parkinson’s disease in Finnish patients. J Med Genet. 39(6):400–402. https://doi.org/10.1136/jmg.39.6.400
Article
CAS
PubMed
PubMed Central
Google Scholar
Möller JC, Depboylu C, Kölsch H, Lohmüller F, Bandmann O, Gocke P et al (2004) Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson’s disease. Neurosci Lett. 359(3):195–197. https://doi.org/10.1016/j.neulet.2004.01.058
Article
CAS
PubMed
Google Scholar
Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kuno S (2000) Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson’s disease. Neurosci Lett. 284(1-2):73–76. https://doi.org/10.1016/s0304-3940(00)00991-5
Article
CAS
PubMed
Google Scholar
Schulte T, Schöls L, Müller T, Woitalla D, Berger K, Krüger R (2002) Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson’s disease. Neurosci Lett. 326(1):70–72. https://doi.org/10.1016/s0304-3940(02)00301-4
Article
CAS
PubMed
Google Scholar
Nishimura M, Kuno S, Kaji R, Yasuno K, Kawakami H (2005) Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson’s disease. Mov Disord. 20(7):901–902. https://doi.org/10.1002/mds.20477
Article
PubMed
Google Scholar
Hu W, Chen Y, Zhao H (2017) Association of pro-inflammatory cytokine gene polymorphisms with Parkinson’s disease in Chinese population. Int J Clin Exp Med. 10(2):3661–3668
CAS
Google Scholar
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Gorzkowska A, Opala G et al (2008) Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson’s disease patients. Parkinsonism Relat Disord. 14(8):636–640. https://doi.org/10.1016/j.parkreldis.2008.02.001
Article
CAS
PubMed
Google Scholar
Liu Z, Guo J, Wang Y, Li K, Kang J, Wei Y et al (2016) Lack of association between IL-10 and IL-18 gene promoter polymorphisms and Parkinson’s disease with cognitive impairment in a Chinese population. Sci Rep. 6:19021. https://doi.org/10.1038/srep19021
Article
CAS
PubMed
PubMed Central
Google Scholar
Nie K, Zhang Y, Gan R, Wang L, Zhao J, Huang Z et al (2013) Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson’s disease with cognitive impairment in the Han Chinese population. Neurosci Lett. 541:111–115. https://doi.org/10.1016/j.neulet.2013.02.024
Article
CAS
PubMed
Google Scholar
Redenšek S, Flisar D, Kojović M, Kramberger MG, Georgiev D, Pirtošek Z et al (2019) Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease. J Neuroinflammation. 16(1):50. https://doi.org/10.1186/s12974-019-1439-y
Article
PubMed
PubMed Central
Google Scholar
Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kaji R et al (2001) Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson’s disease. Neurosci Lett. 311(1):1–4. https://doi.org/10.1016/s0304-3940(01)02111-5
Article
CAS
PubMed
Google Scholar
Fahmy E, Rabah A, Sharaf S, Helmy H, Kamal A (2019) Interleukin-18 promoter polymorphisms and idiopathic Parkinson’s disease: an Egyptian study. Acta Neurol Belg. 119(2):219–224. https://doi.org/10.1007/s13760-018-0927-7
Article
PubMed
Google Scholar
Nishimura M, Kuno S, Mizuta I, Ohta M, Maruyama H, Kaji R et al (2003) Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson’s disease. Mov Disord. 18(8):953–955. https://doi.org/10.1002/mds.10462
Article
PubMed
Google Scholar
Gao L, Tang H, Nie K, Wang L, Zhao J, Gan R et al (2015) MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort. Neurol Sci. 36(4):571–576. https://doi.org/10.1007/s10072-014-1990-3
Article
PubMed
Google Scholar
Wang EH, Hong CJ, Yeh HL, Liou YJ, Yang AC, Liu ME et al (2013) Interleukin-1 alpha (rs1800587) genetic polymorphism is associated with specific cognitive functions but not depression or loneliness in elderly males without dementia. Neurosci Lett. 556:69–72. https://doi.org/10.1016/j.neulet.2013.09.057
Article
CAS
PubMed
Google Scholar
Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM et al (2002) Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 54(2):82–86. https://doi.org/10.1007/s00251-002-0445-9
Article
CAS
PubMed
Google Scholar
Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M (2016) Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 13(1):297. https://doi.org/10.1186/s12974-016-0763-8
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D et al (2008) Human interleukin-10 gene transfer is protective in a rat model of Parkinson’s disease. Mol Ther. 16(8):1392–1399. https://doi.org/10.1038/mt.2008.113
Article
CAS
PubMed
PubMed Central
Google Scholar
Schröder JB, Pawlowski M, Meyer Zu Hörste G, Gross CC, Wiendl H, Meuth SG et al (2018) Immune cell activation in the cerebrospinal fluid of patients with Parkinson’s disease. Front Neurol. 9:1081. https://doi.org/10.3389/fneur.2018.01081
Article
PubMed
PubMed Central
Google Scholar
Starhof C, Winge K, Heegaard NHH, Skogstrand K, Friis S, Hejl A (2018) Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes. J Neuroinflammation. 15(1):305. https://doi.org/10.1186/s12974-018-1339-6
Article
CAS
PubMed
PubMed Central
Google Scholar
Rathnayake D, Chang T, Udagama P (2019) Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson’s disease of varying durations: a case-control study. BMC Neurol. 19(1):56. https://doi.org/10.1186/s12883-019-1286-6
Article
CAS
PubMed
PubMed Central
Google Scholar
Larsson L, Rymo L, Berglundh T (2010) Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production. Genes Immun. 11(2):181–187. https://doi.org/10.1038/gene.2009.103
Article
CAS
PubMed
Google Scholar
Hu J, Hou S, Zhu X, Fang J, Zhou Y, Liu Y et al (2015) Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population. Mol Vis. 21:589–603
CAS
PubMed
PubMed Central
Google Scholar
Gonzalez-Hormazabal P, Romero S, Musleh M, Bustamante M, Stambuk J, Pisano R et al (2018) IL-8-251 T>A (rs4073) polymorphism is associated with prognosis in gastric cancer patients. Anticancer Res 38(10):5703–5708. https://doi.org/10.21873/anticanres.12907
Article
CAS
PubMed
Google Scholar
Gharesouran J, Rezazadeh M, Mojtaba S, Ardebili M (2013) Investigation of five polymorphic DNA markers associated with late onset Alzheimer’s disease. Genetika. 45(2):503–514. https://doi.org/10.2298/GENSR1302503G
Article
Google Scholar
Khorram Khorshid HR, Manoochehri M, Nasehi L, Ohadi M, Rahgozar M, Kamali K (2012) Ccr2-64i and Ccr5 Δ32 polymorphisms in patients with late-onset Alzheimer’s disease; a study from Iran (Ccr2-64i And Ccr5 Δ32 polymorphisms in Alzheimer’s disease). Iran J Basic Med Sci. 15(4):937–944
PubMed
PubMed Central
Google Scholar